Skip to main content
Premium Trial:

Request an Annual Quote

Walter Narajowski

Walter Narajowski has joined the board of MDxHealth, the firm said. Currently senior vice president and general manager of Roka Bioscience, he has more than 25 years of experience in the medical diagnostics industry. Before Roka, Narajowski was CEO of Pathway Diagnostics, which was acquired by Quest Diagnostics in 2008. He has spent most of his career at Abbott Laboratories where he held various positions, including vice president, GM of critical care products; VP, GM of the infusion pump business; and GM of physician office diagnostics.

The company also announced that Mark Myslinksi has stepped down from its board after five years.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.